TET2 and acute myeloid leukemia: This may explain why some mutations increasing self-renewal such as TET2 [89] and DNMT3A [90] are early events in AML, increasing the probability of a secondary driver mutation that can reach fixation without extinction of the preleukemic clone due to drift.